Lin, C., & Tsai, Y. (2016). Axial length, refraction, and retinal vascularization 1 year after ranibizumab or bevacizumab treatment for retinopathy of prematurity. Clin Ophthalmol.
Citación estilo ChicagoLin, Chun-Ju, y Yi-Yu Tsai. "Axial Length, Refraction, and Retinal Vascularization 1 Year After Ranibizumab or Bevacizumab Treatment for Retinopathy of Prematurity." Clin Ophthalmol 2016.
Cita MLALin, Chun-Ju, y Yi-Yu Tsai. "Axial Length, Refraction, and Retinal Vascularization 1 Year After Ranibizumab or Bevacizumab Treatment for Retinopathy of Prematurity." Clin Ophthalmol 2016.
Precaución: Estas citas no son 100% exactas.